Autoantibodies to human melanocyte-specific protein Pmel17 in the sera of vitiligo patients: A sensitive and quantitative radioimmunoassay (RIA)

Clinical and Experimental Immunology

Volumn 114, Issue 3, 1998, Pages 333-338

  Kemp, E H ^a   Gawkrodger, D J ^a   Watson, P F ^a   Weetman, A P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Autoantigen; Autoimmunity; gp100; Pmel17; Vitiligo

Indexed keywords

AUTOANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ARTICLE; CROSS REACTION; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RADIOIMMUNOASSAY; VITILIGO;

ABSORPTION; ADOLESCENT; ADULT; AGED; ANIMALS; AUTOANTIBODIES; CALCIUM CHANNELS; COS CELLS; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; PRECIPITIN TESTS; PROTEIN BIOSYNTHESIS; PROTEINS; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY; SULFUR RADIOISOTOPES; TRANSCRIPTION, GENETIC; TRPC CATION CHANNELS; VITILIGO;

EID: 0031737189     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00746.x     Document Type: Article

References (32)

1. Naughton GK, Eisinger M, Bystryn JC. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation. J Invest Dermatol 1983; 81:540-2.
2. Naughton GK, Reggiardo D, Bystryn JC. Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol 1986; 15:978-81.
3. Harning R, Cui J, Bystryn JC. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol 1991; 97:1078-80.
4. Norris DA, Kissinger RM, Naughton GK, Bystryn JC. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity (ADDC). J Invest Dermatol 1988; 90:783-9.
5. Cui J, Harning R, Henn M, Bystryn JC. Identification of pigment cell antigens defined by vitiligo antibodies. J Invest Dermatol 1992; 98:162-5.
6. Song YH, Connor E, Li Y, Zorovich B, Balducci P, Maclaren N. The role of tyrosinase in autoimmune vitiligo. Lancet 1994; 344:1049-52.
7. Baharav E, Merimski O, Shoenfeld Y, Zigelman R, Gilbrund B, Yecheskel G. Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol 1996; 105:84-88.
8. 35S-labelled recombinant human tyrosinase in a radioimmunoassay. J Invest Dermatol 1997; 109:69-73.
9. Kemp EH, Gawkrodger DJ, Watson PF, Weetman AP. Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin Exp Immunol 1997; 109:495-500.
10. Cui J, Arita Y, Bystryn JC. Characterisation of vitiligo antigens. Pigment Cell Res 1995; 8:53-59.
11. Kemp EH, Waterman EA, Gawkrodger DJ, Watson PF, Weetman AP. Autoantibodies to tyrosinase-related protein-1 (TRP-1) detected in the sera of vitiligo patients using a quantitative radiobinding assay. Brit J Dermatol 1998; in press.
12. Austin LM, Boissy RE. Mammalian tyrosinase-related protein-1 is recognised by autoantibodies from vitiliginous Smyth chickens. Am J Pathol 1995; 146:1529-41.
13. Zhou B-K, Kobayashi T, Donatien PD, Bennett DC, Hearing VJ, Orlow SJ. Identification of a melanosomal matrix protein encoded by the murine si (silver) locus using 'organelle scanning'. Proc Natl Acad Sci USA 1994; 91:7076-80.
14. Kobayashi T, Urabe K, Orlow SJ, Higashi K, Imokawa G, Kwon BS, Potter B, Hearing VJ. The Pme117/Silver locus protein. Characterisation and investigation of its melanogenic function. J Biol Chem 1994; 269:29198-205.
15. Kwon BS. Pigmentation genes: the tyrosinase gene family and the pme1 17 gene family. J Invest Dermatol 1993; 100:134S-40S.
16. Kwon BS, Halaban R, Kim GS, Usack L, Pomerantz SH, Haq AK. A melanocyte-specific cDNA clone whose expression is inducible by MSH and IBMX. Mol Biol Med 1987; 4:339-55.
17. Kwon BS, Chintamaneni C, Kozak CA et al. A melanocyte-specific gene, Pme117, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12. Proc Natl Acad Sci USA 1991; 88:9228-32.
18. Bailin T, Lee S-T, Spritz RA. Genomic organisation and sequence of D12S53E (Pme117), the human homologue of the mouse silver (si) locus. J Invest Dermatol 1996; 106:24-27.
19. Mochii M, Agata K, Eguchi G. Complete sequence and expression of a cDNA encoding 115-kD melanosomal matrix protein. Pigment Cell Res 1991; 4:41-47.
20. Bakker ABH, Scheurs MWJ, de Boer AJ, Kawakami Y, Rosenberg SA, Adema GJ, Figdor CG. Melanocyte lineage-specific antigen gp100 is recognised by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med 1994; 179:1005-9.
21. Adema GJ, de Boer AJ, Vogel AM, Loenen WAM, Figdor CG. Molecular characterisation of the melanocyte lineage-specific antigen gp100. J Biol Chem 1994; 269:20126-33.
22. Kawakami Y, Eliyahu S, Delgado CH et al. Identification of a human melanoma antigen recognised by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 1994; 91:6458-62.
23. Maresh GA, Marken JS, Neubauer M, Aruffo A, Hellstrom I, Hellstrom KE, Marquardt H. Cloning and expression of the gene for the melanoma-associated ME20 antigen. DNA Cell Biol 1994; 13:87-95.
24. Falorni A, Grubin CE, Takei I et al. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 1994; 19:113-25.
25. Falorni A, Nikoshokov A, Laureti S et al. High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab 1995; 80:2752-5.
26. Peterson P, Perheentupa J, Krohn KJE. Detection of candidal antigens in autoimmune polyglandular syndrome type 1. Clin Diag Lab Immunol 1996; 3:290-4.
27. Tsukamoto K, Jackson IJ, Urabe K, Montague PM, Hearing VJ. A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J 1992; 11:519-26.
28. Schreurs MJW, de Boer AJ, Schmidt A, Figdor CG, Adema GJ. Cloning, expression and tissue distribution of the murine homologue of the melanocyte lineage-specific antigen gp100. Melanoma Res 1997; 7:463-70.
29. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd edn. New York: Cold Spring Harbor Laboratory Press, 1989.
30. Yokoyama K, Suzuki H, Yasumoto K, Tomita Y, Shibahara S. Molecular cloning and functional analysis of cDNA coding for human DOPAchrome tautomerase/tyrosinase-related protein-2. Biochim Biophys Acta 1994; 1217:317-21.
31. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
32. Fishman P, Aziz E, Shoenfeld Y et al. Vitiligo autoantibodies are effective against melanoma. Cancer 1993; 72:2365-9.